Lantheus and RefleXion Announce Development and Commercialization Collaboration with the Potential to Improve Future Prostate Cancer Treatment
September 13, 2021 07:30 ET
|
Lantheus Holdings, Inc.; RefleXion Medical, Inc.
NORTH BILLERICA, Mass. and HAYWARD, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) and RefleXion Medical, Inc., today announced a development and...
Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting
September 10, 2021 08:30 ET
|
Lantheus Medical Imaging
Highlights Piflufolastat F 18’s Potential to Change Initial Risk Assessment and Intended Patient Management in High-Risk Prostate Cancer Identified Regional Lymph Node and/or Distant Metastases in...
Lantheus Holdings to Present at Upcoming Investor Conferences
September 02, 2021 08:00 ET
|
Lantheus Medical Imaging
NORTH BILLERICA, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging...